Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice

Oncogene

Volumn 22, Issue 29, 2003, Pages 4581-4585

  Gutmann, D H ^a,c   Winkeler, E ^a   Kabbarah, O ^a   Hedrick, N ^a   Dudley, S ^b   Goodfellow, P J ^a   Liskay, R M ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Box 8111 ^*  (United States)

Author keywords

Leukemia; Mismatch repair; Neurofibromin; Tumor suppressor gene

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NEUROFIBROMIN; NITRIC OXIDE SYNTHASE; PROTEIN MLH1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GENE; GENE EXPRESSION; GENE INACTIVATION; HETEROZYGOSITY; IMMUNOREACTIVITY; LEUKEMOGENESIS; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOUSE; MYELOID LEUKEMIA; NEUROFIBROMATOSIS; NF1 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGE FACTORS; ANIMALS; B-LYMPHOCYTES; BASE PAIR MISMATCH; CARRIER PROTEINS; DNA REPAIR; GENE SILENCING; HETEROZYGOTE; HOMOZYGOTE; LEUKEMIA, MYELOID; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; NUCLEAR PROTEINS; SURVIVAL RATE; THORAX;

ANIMALIA;

EID: 0041667820     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206768     Document Type: Article

References (31)

1. Birnbaum RA, O'Marcaigh A, Wardak Z, Zhang YY, Dranoff G, Jacks T, Clapp DW and Shannon KM. (2000). Mol. Cell, 5, 189-195.
2. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava D. (1998). Cancer Res., 58, 5248-5257.
3. Buermeyer AB, Wilson-Van Patten C, Baker SM and Liskay RM. (1999). Cancer Res., 59, 538-541.
4. Cohn DE, Mutch DG, Herzog TJ, Rader JS, Dintzis SM, Gersell DJ, Todd CR and Goodfellow PJ. (2001). Genes Chromosomes Cancer, 32, 295-301.
5. Cooper LJ, Shannon KM, Loken MR, Weaver M, Stephens K and Sievers EL. (2000). Blood, 96, 2310-2313.
6. Edelmann W, Yang K, Kuraguchi M, Heyer J, Lia M, Kneitz B, Fan K, Brown AM, Lipkin M and Kucherlapati R. (1999). Cancer Res., 59, 1301-1307.
7. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A and Viskochil D. (1997). JAMA, 278, 51-57.
8. Gutmann DH, Donahoe J, Brown T, James CD and Perry A. (2000). Neuropathol. Appl. Neurobiol., 26, 361-367.
9. Heinen CD, Schmutte C and Fishel R. (2002). Cancer Biol. Ther., 1, 477-485.
10. Ingram DA, Hiatt K, King AJ, Fisher L, Shivakumar R, Derstine C, Wenning MJ, Diaz B, Travers JB, Hood A, Marshall M, Williams DA and Clapp DW. (2001). J. Exp. Med., 194, 57-69.
11. Ingram DA, Zhang L, McCarthy J, Wenning MJ, Fisher L, Yang FC, Clapp DW and Kapur R. (2002). Blood, 100, 3656-3662.
12. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A and Weinberg RA. (1994). Nat. Genet., 7, 353-361.
13. Kim TJ, Cariappa A, Iacomini J, Tang M, Shih S, Bernards A, Jacks T and Pillai S. (2002). Mol. Immunol., 38, 701-708.
14. Kolodner RD and Marsischky GT. (1999). Curr. Opin. Genet. Dev., 9, 89-96.
15. Kowalski LD, Mutch DG, Herzog TJ, Rader JS and Goodfellow PJ. (1997). Genes Chromosomes Cancer, 18, 219-227.
16. Li Y and White R. (1996). Cancer Res., 56, 2872-2876.
17. Mahgoub N, Taylor BR, Le Beau MM, Gratiot M, Carlson KM, Atwater SK, Jacks T and Shannon KM. (1999). Blood, 93, 3617-3623.
18. Maris JM, Wiersma SR, Mahgoub N, Thompson P, Geyer RJ, Hurwitz CG, Lange BJ and Shannon KM. (1997). Cancer, 79, 1438-1446.
19. Prolla TA, Baker SM, Harris AC, Tsao JL, Yao X, Bronner CE, Zheng B, Gordon M, Reneker J, Arnheim N, Shibata D, Bradley A and Liskay RM. (1998). Nat. Genet., 18, 276-279.
20. Ricciardone MD, Ozcelik T, Cevher B, Ozdag H, Tuncer M, Gurgey A, Uzunalimoglu O, Cetinkaya H, Tanyeli A, Erken E and Ozturk M. (1999). Cancer Res., 59, 290-293.
21. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P and McCormick F. (1994). N. Engl. J. Med., 330, 597-601.
22. Shannon KM, Le Beau MM, Largaespada DA and Killeen N. (2001). Semin. Cancer Biol., 11, 191-200.
23. Shoemaker AR, Haigis KM, Baker SM, Dudley S, Liskay RM and Dove WF. (2000). Oncogene, 19, 2774-2779.
24. Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M and Shannon K. (1997). N. Engl. J. Med., 336, 1713-1720.
25. Side LE, Emanuel PD, Taylor B, Franklin J, Thompson P, Castleberry RP and Shannon KM. (1998). Blood, 92, 267-272.
26. Stiller CA, Chessells JM and Fitchett M. (1994). Br. J. Cancer, 70, 969-972.
27. Wang H, Douglas W, Lia M, Edelmann W, Kucherlapati R, Podsypanina K, Parsons R and Ellenson LH. (2002). Am. J. Pathol., 160, 1481-1486.
28. Wang Q, Lasset C, Desseigne F, Frappaz D, Bergeron C, Navarro C, Ruano E and Puisieux A. (1999). Cancer Res., 59, 294-297.
29. Wang Q, Montmain G, Ruano E, Upadhyaya M, Dudley S, Liskay RM, Thibodeau SN and Puisieux A. (2003). Hum. Genet., 112, 117-123.
30. Whiteside D, McLeod R, Graham G, Steckley JL, Booth K, Somerville MJ and Andrew SE. (2002). Cancer Res., 62, 359-362.
31. Yao X, Buermeyer AB, Narayanan L, Tran D, Baker SM, Prolla TA, Glazer PM, Liskay RM and Arnheim N. (1999). Proc. Natl. Acad. Sci. USA, 96, 6850-6855.